HFL-Park Place is a joint venture between Haden Freeman Group and Park Place Research.
Haden Freeman Limited (HFL) is well known for its expertise in the
design and construction of pharmaceutical ingredient (API) plants
for the application of risk-based approach to process control technology
and systems.
Commitment to excellence
As both companies share a common commitment to excellence in process innovation,
it is natural that they should join together to offer an unparalleled range of
services to the pharmaceutical industry.
As both companies share a common commitment to excellence in process innovation, it is natural that they should join together to offer an unparalleled range of services to the pharmaceutical industry.
